Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pientzehuang versus Ku Huang granules for chronic hepatitis B with jaundice
ChiCTR2300073745Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jul 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Pien Tze Huang in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Change in total bilirubin from baseline. Started Jul 2023; status: recruiting.
02
Drugs
Pien Tze Huang
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2300073745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073745.